Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Family tissue bank aims to unlock pancreatic cancer secrets

NCT ID NCT00835133

Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects blood samples and medical information from people who have at least two relatives with pancreatic cancer, or one relative with pancreatic cancer and one with melanoma. The goal is to create a resource that scientists can use to study why pancreatic cancer runs in some families. Over 1,100 participants have already joined this registry at the Mayo Clinic.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could help researchers better understand familial pancreatic cancer and possibly find new ways to detect or treat it in the future.
What could go wrong
This is a registry study, not a treatment trial. It collects samples for future research, so there is no direct benefit to participants and no guarantee that the data will lead to new discoveries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,122 people

The number who actually took part.

Started

Aug 2002

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Familial pancreatic cancer kindred

Ages

18 to 120 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

DISEASE CHARACTERISTICS: * Meets 1 of the following criteria: * Has at least 2 blood relatives with pancreatic cancer (both must be related) * Has at least 1 blood relative with pancreatic cancer and 1 with melanoma (both must be related) PATIENT CHARACTERISTICS: * Mentally competent and able to provide informed consent * Able to understand and read English PRIOR CONCURRENT THERAPY: * Not specified

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Familial pancreatic cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

familial pancreatic carcinoma melanoma neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Familial pancreatic cancer

Contacts and locations

Locations

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.